21 August 2014

The latest supply chain news, views and features for the healthcare sector


GSK explains award-winning supply chain transformation
GlaxoSmithKline cut lead times in its R&D lab supplies operation and more than doubled OTIF through a series of initiatives – and it went on to win not one, but two European Supply Chain Excellence Awards last year ...

arvato in joint healthcare venture in Switzerland
arvato Healthcare has entered a partnership with Swiss pre-wholesale company, Voigt Industrie Service, to offer its customers an integrated solution for the final-mile delivery of medication in Switzerland...

Cardinal Health tops healthcare supply chains
Cardinal Health has come out top in Gartner’s healthcare supply chain rankings for 2013...

More News


Tricky operations
Getting closer to the customer is the goal of most organisations and this is particularly true for manufacturers of implantable medical devices. Although there is considerable product innovation to provide better clinical results, the supply...

Efficiency is on the cards
The drive for efficiency in physical supply chains has benefited firms prepared to adopt new models and technology. Meanwhile, the financial supply chain has ground to make up if it is to avoid becoming a significant bottleneck. ...

More Viewpoint


The English patient
Healthcare is a highly political subject. When the UK’s NHS outsourced its supply chain to a logistics services company close scrutiny ensued. But the stakes are high – assurances were given that savings of €127million would bemade each year for ten...

What's to be heard at ESC 2008
The sixth in the series, the Extended Supply Chain 2008 conference looks set to surpass all others to date. ...

More Features

Corporate Insight

Balancing risk
Two major humanitarian disasters - the Burmese cyclone and the Chinese earthquake - provided a sombre backdrop to ''Supply Chain Standard''s Roundtable discussion on supply chain risk. But as Dave Food, business development director from the meeting's ...

Taking the trial out of pharmaceutical testing
Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and - given time limitations on patents - the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most...

More Corporate Insight
Executive Jobs
Job Title Job Location Job Position
Account & Business Development Manager ... East Midlands Permanent
Account Development Manager ... Buckinghamshire Permanent
Business Development General Manager ... Derbyshire Permanent
Business Development Manager ... West Midlands Permanent
Business Development Manager ... West Midlands Permanent
Business Development Manager ... Lancashire Permanent
More Jobs

User Account Logon Form

Quick Search Form

Advanced Search